HL
BNTX icon

Harding Loevner’s BioNTech BNTX Stock Holding History

Harding Loevner’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,325
Closed -$276K – 68
2024
Q3 		$276K Sell
2,325
-2,924,436
-100% -$269M ﹤0.01% 66
2024
Q2 		$235M Sell
2,926,761
-891,402
-23% -$81.5M 1.3% 27
2024
Q1 		$352M Sell
3,818,163
-126,311
-3% -$12.1M 2.17% 15
2023
Q4 		$411M Buy
+3,944,474
New +$397M 2.31% 12
2022
Q4 		– Sell
-1,202
Closed -$162K – 95
2022
Q3 		$162K Hold
1,202
– – ﹤0.01% 82
2022
Q2 		$179K Buy
+1,202
New +$184K ﹤0.01% 84

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return